These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34635222)

  • 1. Chemometric analysis of the global pattern of volatile organic compounds in the exhaled breath of patients with COVID-19, post-COVID and healthy subjects. Proof of concept for post-COVID assessment.
    Zamora-Mendoza BN; Díaz de León-Martínez L; Rodríguez-Aguilar M; Mizaikoff B; Flores-Ramírez R
    Talanta; 2022 Jan; 236():122832. PubMed ID: 34635222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of profiles of volatile organic compounds in exhaled breath by means of an electronic nose as a proposal for a screening method for breast cancer: a case-control study.
    Díaz de León-Martínez L; Rodríguez-Aguilar M; Gorocica-Rosete P; Domínguez-Reyes CA; Martínez-Bustos V; Tenorio-Torres JA; Ornelas-Rebolledo O; Cruz-Ramos JA; Balderas-Segura B; Flores-Ramírez R
    J Breath Res; 2020 Sep; 14(4):046009. PubMed ID: 32698165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of global chemical patterns in exhaled breath for the discrimination of lung damage in postCOVID patients using olfactory technology.
    Zamora-Mendoza BN; Sandoval-Flores H; Rodríguez-Aguilar M; Jiménez-González C; Alcántara-Quintana LE; Berumen-Rodríguez AA; Flores-Ramírez R
    Talanta; 2023 May; 256():124299. PubMed ID: 36696734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of volatile organic compounds in the urine of patients with cervical cancer. Test concept for timely screening.
    Díaz de León-Martínez L; Flores-Ramírez R; López-Mendoza CM; Rodríguez-Aguilar M; Metha G; Zúñiga-Martínez L; Ornelas-Rebolledo O; Alcántara-Quintana LE
    Clin Chim Acta; 2021 Nov; 522():132-140. PubMed ID: 34418363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of breath-prints for the COPD detection associated with smoking and household air pollution by electronic nose.
    Rodríguez-Aguilar M; Díaz de León-Martínez L; Gorocica-Rosete P; Padilla RP; Thirión-Romero I; Ornelas-Rebolledo O; Flores-Ramírez R
    Respir Med; 2020 Mar; 163():105901. PubMed ID: 32125969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of chemoresistive gas sensors and chemometric analysis to differentiate the fingerprints of global volatile organic compounds from diseases. Preliminary results of COPD, lung cancer and breast cancer.
    Rodríguez-Aguilar M; Díaz de León-Martínez L; Gorocica-Rosete P; Pérez-Padilla R; Domínguez-Reyes CA; Tenorio-Torres JA; Ornelas-Rebolledo O; Mehta G; Zamora-Mendoza BN; Flores-Ramírez R
    Clin Chim Acta; 2021 Jul; 518():83-92. PubMed ID: 33766555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of volatile organic compounds of breath and urine for distinguishing patients with liver cirrhosis from healthy controls by using electronic nose and voltammetric electronic tongue.
    Zaim O; Diouf A; El Bari N; Lagdali N; Benelbarhdadi I; Ajana FZ; Llobet E; Bouchikhi B
    Anal Chim Acta; 2021 Nov; 1184():339028. PubMed ID: 34625262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a characteristic VOCs pattern in the exhaled breath of post-COVID subjects: are metabolic alterations induced by the infection still detectable?
    Di Gilio A; Palmisani J; Picciariello A; Zambonin C; Aresta A; De Vietro N; Franchini SA; Ventrella G; Nisi MR; Licen S; Barbieri P; Altomare DF; de Gennaro G
    J Breath Res; 2023 Jul; 17(4):. PubMed ID: 37379826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of chemical breath-prints through olfactory technology for the discrimination between SARS-CoV-2 infected patients and controls.
    Rodríguez-Aguilar M; Díaz de León-Martínez L; Zamora-Mendoza BN; Comas-García A; Guerra Palomares SE; García-Sepúlveda CA; Alcántara-Quintana LE; Díaz-Barriga F; Flores-Ramírez R
    Clin Chim Acta; 2021 Aug; 519():126-132. PubMed ID: 33901429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exhaled volatile organic compounds analysis by e-nose can detect idiopathic pulmonary fibrosis.
    Dragonieri S; Scioscia G; Quaranta VN; Carratu P; Venuti MP; Falcone M; Carpagnano GE; Foschino Barbaro MP; Resta O; Lacedonia D
    J Breath Res; 2020 Jul; 14(4):047101. PubMed ID: 32320958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exhaled-breath Testing for Prostate Cancer Based on Volatile Organic Compound Profiling Using an Electronic Nose Device (Aeonose™): A Preliminary Report.
    Waltman CG; Marcelissen TAT; van Roermund JGH
    Eur Urol Focus; 2020 Nov; 6(6):1220-1225. PubMed ID: 30482583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrafast gas chromatography coupled to electronic nose to identify volatile biomarkers in exhaled breath from chronic obstructive pulmonary disease patients: A pilot study.
    Rodríguez-Aguilar M; Ramírez-García S; Ilizaliturri-Hernández C; Gómez-Gómez A; Van-Brussel E; Díaz-Barriga F; Medellín-Garibay S; Flores-Ramírez R
    Biomed Chromatogr; 2019 Dec; 33(12):e4684. PubMed ID: 31423612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evening and morning exhaled volatile compound patterns are different in obstructive sleep apnoea assessed with electronic nose.
    Kunos L; Bikov A; Lazar Z; Korosi BZ; Benedek P; Losonczy G; Horvath I
    Sleep Breath; 2015 Mar; 19(1):247-53. PubMed ID: 24840212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-COVID syndrome screening through breath analysis using electronic nose technology.
    V R N; Mohapatra AK; V K U; Lukose J; Kartha VB; Chidangil S
    Anal Bioanal Chem; 2022 May; 414(12):3617-3624. PubMed ID: 35303135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-Term Effect of Cigarette Smoke on Exhaled Volatile Organic Compounds Profile Analyzed by an Electronic Nose.
    Dragonieri S; Quaranta VN; Buonamico E; Battisti C; Ranieri T; Carratu P; Carpagnano GE
    Biosensors (Basel); 2022 Jul; 12(7):. PubMed ID: 35884323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of an e-nose performance for the detection of COVID-19 specific biomarkers.
    Ghazaly C; Biletska K; Thevenot EA; Devillier P; Naline E; Grassin-Delyle S; Scorsone E
    J Breath Res; 2023 Feb; 17(2):. PubMed ID: 36749983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exhaled breath profiling by electronic nose enabled discrimination of allergic rhinitis and extrinsic asthma.
    Dragonieri S; Quaranta VN; Carratu P; Ranieri T; Resta O
    Biomarkers; 2019 Feb; 24(1):70-75. PubMed ID: 30074408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of age and gender on the profile of exhaled volatile organic compounds analyzed by an electronic nose.
    Dragonieri S; Quaranta VN; Carratu P; Ranieri T; Resta O
    J Bras Pneumol; 2016 Apr; 42(2):143-5. PubMed ID: 27167436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breath Prints for Diagnosing Asthma in Children.
    Sas V; Cherecheș-Panța P; Borcau D; Schnell CN; Ichim EG; Iacob D; Coblișan AP; Drugan T; Man SC
    J Clin Med; 2023 Apr; 12(8):. PubMed ID: 37109167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory Asthma Phenotype Discrimination Using an Electronic Nose Breath Analyzer.
    Plaza V; Crespo A; Giner J; Merino JL; Ramos-Barbón D; Mateus EF; Torrego A; Cosio BG; Agustí A; Sibila O
    J Investig Allergol Clin Immunol; 2015; 25(6):431-7. PubMed ID: 26817140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.